LivaNova (LIVN) Gross Profit (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.66% |
| Dec 31, 2025 | -2.08% |
| Sep 30, 2025 | 2.45% |
| Jun 30, 2025 | 10.51% |
| Mar 31, 2025 | 0.88% |
| Dec 31, 2024 | -3.01% |
| Sep 30, 2024 | 2.86% |
| Jun 30, 2024 | 5.74% |
| Mar 31, 2024 | 16.29% |
| Dec 31, 2023 | -13.41% |
| Sep 30, 2023 | -1.65% |
| Jun 30, 2023 | 17.87% |
| Mar 31, 2023 | -5.14% |
| Dec 31, 2022 | 7.37% |
| Sep 30, 2022 | -7.29% |
| Jun 30, 2022 | 9.44% |
| Mar 31, 2022 | -16.46% |
| Dec 31, 2021 | 19.55% |
| Sep 30, 2021 | -2.10% |
| Jun 30, 2021 | 5.43% |
| Mar 31, 2021 | -2.09% |
| Dec 31, 2020 | 13.08% |
| Sep 30, 2020 | 28.37% |
| Jun 30, 2020 | -30.45% |
| Mar 31, 2020 | -4.20% |
| Dec 31, 2019 | -5.44% |
| Sep 30, 2019 | -9.76% |
| Jun 30, 2019 | 21.42% |
| Mar 31, 2019 | -19.37% |
| Dec 31, 2018 | 18.47% |
| Sep 30, 2018 | -10.11% |
| Jun 30, 2018 | 19.67% |
| Mar 31, 2018 | -5.80% |
| Dec 31, 2017 | 6.31% |
| Sep 30, 2017 | -4.84% |
| Jun 30, 2017 | 15.20% |
| Mar 31, 2017 | 17.72% |
| Dec 31, 2016 | -18.51% |
| Sep 30, 2016 | 3.67% |
| Jun 30, 2016 | 12.69% |
| Oct 18, 2015 | -18.99% |
| Jul 24, 2015 | 7.67% |